Latest Biotech News

DuPont (NYSE: DD) and Bayer CropScience have entered into a series of long-term business agreements related to key plant biotechnology traits and enabling technologies that will help increase agricultural productivity around the world.   These agreements create significant value capture opportunities for both parties through herbicide and seed sales... 

Syngenta Biotechnology, Inc. announced today that it has entered into an exclusive worldwide research and commercial license agreement for Chromatin’s proprietary gene stacking technology in sugar cane.   Chromatin has developed a novel approach to gene stacking, using the plant’s own DNA to deliver several genes. Under this agreement,... 

Mylan Inc. (Nasdaq: MYL) today announced that it has executed a definitive agreement with Biocon Limited, a publicly traded company on the Indian stock exchanges, for an exclusive collaboration on the development, manufacturing, supply and commercialization of multiple, high value generic biologic compounds for the global marketplace. Through this partnership,... 

Bayer CropScience AG and Monsanto Company have agreed to cross license their respective herbicide tolerance traits in rapeseed/canola on a non-exclusive basis for commercialization within their respective branded canola seed businesses. Canola is a form of rapeseed primarily grown in North America and Australia.   Under the terms of this global agreement,... 

The physicians of Hematology-Oncology Associates, P.C in Albuquerque, N.M., an eight provider community based specialty practice caring for adults with cancers and blood disorders, today announced they have entered into an agreement with Oncology Pharmaceutical Services (OPS) to secure its oncology drug purchasing, distribution services, and the support... 

Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today launched the Staccato Protein Workstation to specifically address bottlenecks in the characterization of biological therapeutics and biogenerics.   With a goal of assuring the quality of therapeutic proteins and...